News · 26 weeks56+10%
2026-03-012026-08-23
Mix2590d
- SEC Filings11(44%)
- Insider7(28%)
- Other3(12%)
- Earnings2(8%)
- Analyst1(4%)
- Offering1(4%)
Latest news
25 items- PRNanox to Report Second Quarter 2026 Financial Results on September 9, 2026PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2026, before market open on Monday, September, 9, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Guy Nathanzon, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q2 2026 Conference Call The live webcast of the conference call may be acce
- PRNanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United KingdomInitial three-year term includes minimum annual license commitments PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. ("Nanox", ("Nanox", or the "Company" NASDAQ:NNOX), a leader in innovative medical imaging technology, today announced its subsidiary, Nanox AI Ltd. ("Nanox AI") entered into a sales reseller agreement with Vertec Scientific Ltd. ("Vertec") for the commercialization of Nanox.AI bone solution (HealthOST) in the United Kingdom. The agreement grants Vertec an exclusive license to market and resell HealthOST in the United Kingdom, subject to Vertec satisfying minimum annual license commitments, over an initial three-year term. Nanox.AI bone solution (HealthOST) is an F
- SECSEC Form 6-K filed by NANO-X IMAGING LTD6-K - Nano-X Imaging Ltd. (0001795251) (Filer)
- SECSEC Form 6-K filed by NANO-X IMAGING LTD6-K - Nano-X Imaging Ltd. (0001795251) (Filer)
- INSIDERChief Executive Officer Meltzer Erez bought $9,726 worth of Ordinary Shares (9,443 units at $1.03) (SEC Form 4)4 - Nano-X Imaging Ltd. (0001795251) (Issuer)
- SECSEC Form 6-K filed by NANO-X IMAGING LTD6-K - Nano-X Imaging Ltd. (0001795251) (Filer)
- SECSEC Form 424B5 filed by NANO-X IMAGING LTD424B5 - Nano-X Imaging Ltd. (0001795251) (Filer)
- SECSEC Form 6-K filed by NANO-X IMAGING LTD6-K - Nano-X Imaging Ltd. (0001795251) (Filer)
- PRNano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesPETACH TIKVA, Israel, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nano-X Imaging Ltd. (NASDAQ:NNOX), ("Nano-X" or the "Company") an innovative medical imaging technology company, today announced that it has entered into a securities purchase agreement with a single long-term institutional investor for the purchase and sale of 8,000,000 Ordinary Shares (or prefunded warrants in lieu of any portion thereof) (the "Ordinary Shares") and warrants to purchase up to 8,000,000 Ordinary Shares at a combined purchase price of $1.00 per Ordinary Share and accompanying warrant (the "Offering"). The warrants will have an exercise price of $1.15 per Ordinary Share, will be exercisable six months following issuanc
- SECSEC Form 144 filed by NANO-X IMAGING LTD144 - Nano-X Imaging Ltd. (0001795251) (Subject)
- INSIDERSEC Form 3 filed by new insider Nathansohn Guy3 - Nano-X Imaging Ltd. (0001795251) (Issuer)
- INSIDERDirector Suesskind Dan S bought $46,500 worth of Ordinary Shares (50,000 units at $0.93) (SEC Form 4)4 - Nano-X Imaging Ltd. (0001795251) (Issuer)
- INSIDERDirector Kainan Noga bought $29,700 worth of Ordinary Shares (33,000 units at $0.90), increasing direct ownership by 424% to 40,792 units (SEC Form 4)4 - Nano-X Imaging Ltd. (0001795251) (Issuer)
- INSIDERCFO Daniel Ran returned $890 worth of Ordinary Shares to the company (1,000 units at $0.89), decreasing direct ownership by 14% to 5,950 units (SEC Form 4)4 - Nano-X Imaging Ltd. (0001795251) (Issuer)
- SECSEC Form 144 filed by NANO-X IMAGING LTD144 - Nano-X Imaging Ltd. (0001795251) (Subject)
- INSIDERChief Executive Officer Meltzer Erez bought $33,480 worth of Ordinary Shares (36,000 units at $0.93) (SEC Form 4)4 - Nano-X Imaging Ltd. (0001795251) (Issuer)
- SECSEC Form 424B5 filed by NANO-X IMAGING LTD424B5 - Nano-X Imaging Ltd. (0001795251) (Filer)
- SECSEC Form 6-K filed by NANO-X IMAGING LTD6-K - Nano-X Imaging Ltd. (0001795251) (Filer)
- SECSEC Form 6-K filed by NANO-X IMAGING LTD6-K - Nano-X Imaging Ltd. (0001795251) (Filer)
- ANALYSTNano-X Imaging downgraded by Alliance Global Partners with a new price targetAlliance Global Partners downgraded Nano-X Imaging from Buy to Neutral and set a new price target of $3.00
- PRNew Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026New SCCT abstracts from Brigham and Women’s Hospital highlight the performance and clinical utility of Nanox.AI’s FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its potential role in supporting guideline-directed preventive care. From incidental finding to clinical action: the AI INFORM randomized trial highlights how AI-detected coronary calcium may help clinicians identify opportunities for preventive lipid-lowering therapy. Nanox.AI Sponsors SCCT Scientific Session, "From Missed Finding to Missed Opportunity: Aortic Valve Calcification on Chest CT," Featuring Ofir Koren, MD, Cedars-Sinai Medical Center, on Sunday, July 12, at 7:30 am PETACH TIKVA, Is
- SECSEC Form 6-K filed by NANO-X IMAGING LTD6-K - Nano-X Imaging Ltd. (0001795251) (Filer)
- INSIDERDirector Alroy Erez sold $1,119 worth of Ordinary Shares (678 units at $1.65), increasing direct ownership by 145% to 17,075 units (SEC Form 4)4 - Nano-X Imaging Ltd. (0001795251) (Issuer)
- PRNanox to Report First Quarter 2026 Financial Results on June 25, 2026PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2026, before market open on Thursday, June 25, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q1 2026 Call Registration The live webcast of the conference call may be accessed
- PRExclusive distribution agreement marks Nanox's entry into the Peruvian marketInitial deployment is expected to include six Nanox.ARC systems under a capex model PETACH TIKVA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (("Nanox", NASDAQ:NNOX), a leader in innovative medical imaging technology, today announced a distribution agreement with Top Med SAC ("Top Med") to deploy the Nanox.ARC system and related services in Peru. Under the agreement, Nanox appointed Top Med as its exclusive distributor of the Nanox.ARC system and Nanox platform in Peru, subject to commercial milestones and regulatory requirements. The agreement is structured as a capex model and includes an expected initial deployment of six Nanox.ARC systems, subject to receipt of t
NNOX FAQ
7 questionsWhat does NANO-X IMAGING LTD do?
Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.Where does NNOX stock trade?
NANO-X IMAGING LTD (NNOX) is listed on NASDAQ.What sector and industry is NNOX in?
NANO-X IMAGING LTD operates in the Health Care sector, Medical Electronics industry.When did NANO-X IMAGING LTD go public?
NANO-X IMAGING LTD (NNOX) completed its IPO in 2020.What are analysts saying about NNOX?
NANO-X IMAGING LTD has had 4 recent analyst actions on file. The most recent action was from Alliance Global Partners: Neutral with a $300.00 price target on 2026-07-07.What companies are similar to NNOX?
Notable peers in the same industry include GEHC (GE HealthCare Technologies Inc.), PHG (Koninklijke Philips N.V. NY Registry Shares), HOLX (Hologic Inc.), BFLY (Butterfly Network Inc.), CHEK (Check-Cap Ltd.). Compare NNOX side-by-side with any of them on Quantisnow.How can I track NNOX on Quantisnow?
Quantisnow aggregates NANO-X IMAGING LTD's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NNOX to receive live email and push alerts on every new disclosure.